Targeted Medical Pharma, Inc. Share Price

Equities

TRGM

US8761401046

Pharmaceuticals

Market Closed - OTC Markets 15:47:54 27/07/2023 BST 5-day change 1st Jan Change
0.0001 USD -.--% Intraday chart for Targeted Medical Pharma, Inc. -.--% -.--%
Sales 2014 7.11M 568M Sales 2015 5.26M 420M Capitalization 429K 34.26M
Net income 2014 -3M -239M Net income 2015 -3M -239M EV / Sales 2014 1.28 x
Net Debt 2014 3.71M 296M Net Debt 2015 5.21M 416M EV / Sales 2015 1.07 x
P/E ratio 2014
-1.37 x
P/E ratio 2015
-0.14 x
Employees 30
Yield 2014 *
-
Yield 2015
-
Free-Float 38.35%
More Fundamentals * Assessed data
Dynamic Chart
Targeted Medical Pharma, Inc. Announces Resignation of William B. Horne as Chief Financial Officer CI
Targeted Medical Pharma, Inc. Announces Resignation of David Silver as Chief Medical Officer and Chairman of the Board of Directors CI
Targeted Medical Pharma, Inc. Announces Executive Changes CI
Targeted Medical Pharma, Inc. Auditor Raises 'Going Concern' Doubt CI
Targeted Medical Pharma, Inc. and Amino Nutritionals LLC Announce Release of THERALEVE CI
Targeted Medical Pharma Finalizes Exclusive Agreement for Distribution in China CI
Targeted Medical Pharma, Inc. Auditor Raises 'Going Concern' Doubt CI
Tauriga Sciences, Inc. Expands Agreement with Targeted Medical Pharma, Inc CI
Targeted Medical Pharma, Inc. Announces Resignation of William E. Shell as Member of the Board CI
Targeted Medical Pharma, Inc. announced that it has received $1.2 million in funding. CI
Targeted Medical Pharma, Inc. announced that it expects to receive $1.2 million in funding. CI
Targeted Medical Pharma Announces Exclusive Product Distribution Agreement with J-Network Inc in Japan CI
Targeted Medical Pharma, Inc. Announces Resignation of Paul Pelosi Jr as Member of Audit Committee, Compensation Committee and Nominating Committee CI
Targeted Medical Pharma, Inc. Announces Expiration of Term of Office of Kim Giffoni as Executive Vice President of Foreign Sales and Investor Relations CI
Targeted Medical Pharma, Inc. Announces Resignation of Dr. Silver as President and Chief Operating Officer CI
More news
1 year
0.00
Extreme 0.0001
0.00
3 years
0.00
Extreme 0.0001
0.10
5 years
0.00
Extreme 0.0001
0.10
10 years
0.00
Extreme 0.0001
0.85
More quotes
Members of the board TitleAgeSince
Director/Board Member 84 31/01/11
Director/Board Member 80 03/03/14
More insiders
Targeted Medical Pharma, Inc. is a medical nutrition company. The Company is engaged in developing amino acid based medical foods and other oral nutrition products for the long-term management of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep, respiratory disorders, allergies and cognitive disorders. It manufactures eight amino acid based medical foods along with the dietary supplements, which include Grotrexa, AppTrim, Hypertensa Advanced and Clearwayz. Its Targeted Cellular Technology is a patented formulation that allows reduced concentrations of amino acids and other ingredients in the milligram range to stimulate the production of neurotransmitters to treat the nutritional deficiencies associated with certain diseases and conditions. The Company’s medical food brands include Theramine, Trepadone, Percura, GABAdone, Sentra PM, AppTrim-D and Sentra AM.
More about the company